Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 120,800
Avg Vol 253,964
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 63%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Ono Pharmaceutical Co., Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for ca...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 81 6 6263 5670
Address:
8-2, Kyutaromachi 1-chome, Chuo-ku, Osaka, Japan
Latest News on OPHLY
No data available.